Genome-wide association study identifies MAPT locus influencing human plasma tau levels

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Neurology

• Publication date

  2017-02-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1212/WNL.0000000000003615PMID 28100725PMCID PMC5317386
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy

  2015influential reference
• Peripheral Total Tau in Military Personnel Who Sustain Traumatic Brain Injuries During Deployment.

  2015cited by this paper
• SmileFinder: a resampling-based approach to evaluate signatures of selection from genome-wide sets of matching allele frequency data in two or more diploid populations

  2015cited by this paper
• Depletion of microglia and inhibition of exosome synthesis halt tau propagation

  2015cited by this paper
• qqman: an R package for visualizing GWAS results using Q-Q and manhattan plots

  2014cited by this paper
• Association of MAPT haplotypes with Alzheimer’s disease risk and MAPT brain gene expression levels

  2014cited by this paper
• Divergent CSF τ alterations in two common tauopathies: Alzheimer's disease and progressive supranuclear palsy

  2014cited by this paper
• Second-generation PLINK: rising to the challenge of larger and richer datasets

  2014cited by this paper
• GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.

  2013cited by this paper
• Variation in tau isoform expression in different brain regions and disease states.

  2013cited by this paper
• Biomarker modeling of Alzheimer's disease.

  2013cited by this paper
• MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies

  2012cited by this paper
• V37 Common variants affect risk for the tauopathy progressive supranuclear palsy

  2011influential reference
• LocusZoom: regional visualization of genome-wide association scan results

  2010cited by this paper
• Genome-wide association study of CSF biomarkers Aβ1-42, t-tau, and p-tau181p in the ADNI cohort

  2010influential reference
• Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study

  2009cited by this paper
• Parkin polymorphisms in progressive supranuclear palsy.

  2008influential reference
• Evolutionary toggling of the MAPT 17q21.31 inversion region

  2008cited by this paper
• Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition

  2008cited by this paper
• Risk alleles for multiple sclerosis identified by a genomewide study.

  2007cited by this paper
• Fine mapping of the MAPT locus using quantitative trait analysis identifies possible causal variants in Alzheimer's disease

  2007cited by this paper
• The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts.

  2007cited by this paper
• Genetic variation at the tau locus and clinical syndromes associated with progressive supranuclear palsy

  2007influential reference
• Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism.

  2006cited by this paper
• Haplotype-specific expression of exon 10 at the human MAPT locus.

  2006cited by this paper
• High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy.

  2005cited by this paper
• Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration

  2005influential reference
• The structure of the tau haplotype in controls and in progressive supranuclear palsy.

  2004cited by this paper
• Tau exon 10 +16 mutation FTDP-17 presenting clinically as sporadic young onset PSP

  2003cited by this paper
• Mental Rotation of Perspective Stimuli in a California Sea Lion (Zalophus californianus)

  2003cited by this paper
• Total tau and phosphorylated tau 181 levels in the cerebrospinal fluid of patients with frontotemporal dementia due to P301L and G272V tau mutations.

  2003cited by this paper
• Steele‐Richardson‐Olszewski syndrome in a patient with a single C212Y mutation in the parkin protein

  2002influential reference
• Neurodegenerative tauopathies.

  2001influential reference
• Association between early-onset Parkinson's disease and mutations in the parkin gene.

  2000cited by this paper
• Association of an extended haplotype in the tau gene with progressive supranuclear palsy.

  1999cited by this paper
• Genetic evidence for the involvement of τ in progressive supranuclear palsy

  1997cited by this paper
• The Future of Genetic Studies of Complex Human Diseases

  1996cited by this paper

• MAPT Subhaplotypes in Different Progressive Supranuclear Palsy Phenotypes

  2025cites this paper
• Genome‐wide association of tau neuroimaging and plasma biomarkers in adults with Down syndrome

  2025cites this paper
• Effect of MAPT gene variations on the brain electrical activity: A multiplex network study

  2025cites this paper
• HMGA1 deficiency: a pathogenic link between tau pathology and insulin resistance

  2025cites this paper
• Cerebral perfusion alterations in healthy young adults due to two genetic risk factors of Alzheimer’s disease: APOE and MAPT

  2025cites this paper
• Overlaps and divergences between tauopathies and synucleinopathies: a duet of neurodegeneration

  2024cites this paper
• Scutellarin Attenuates Microglia Activation in LPS‐Induced BV‐2 Microglia via miRNA‐7036a/MAPT/PRKCG/ERK Axis

  2024cites this paper
• Imaging of Tauopathies with PET Ligands: State of the Art and Future Outlook

  2023cites this paper
• Genetic risks of Alzheimer’s by APOE and MAPT on cortical morphology in young healthy adults

  2023cites this paper
• The heritability of blood‐based biomarkers related to risk of Alzheimer's disease in a population‐based sample of early old‐age men

  2023cites this paper
• A Genetic Validation of the Neurodegeneration Biomarkers Tau-A and Tau-C - A Mendelian Randomization Study

  2023cites this paper
• Meta-analysis of genome-wide association studies identifies ancestry-specific associations underlying circulating total tau levels

  2022cites this paper
• Genome-wide association study of brain tau deposition as measured by 18F-flortaucipir positron emission tomography imaging.

  2022cites this paper
• The genetic and environmental etiology of blood-based biomarkers related to risk of Alzheimer’s Disease in a population-based sample of early old-age men

  2022cites this paper
• Internetwork Connectivity Predicts Cognitive Decline in Parkinson’s and Is Altered by Genetic Variants

  2022cites this paper
• Proteomic, genetic, and epigenetic biomarkers in traumatic brain injury

  2021cites this paper
• An Introduction to Ultrasensitive Assays for Plasma Tau Detection

  2021cites this paper
• Progress regarding the context-of-use of tau as biomarker of Alzheimer’s disease and other neurodegenerative diseases

  2021cites this paper
• Ultrasensitive assays for detection of plasma tau and phosphorylated tau 181 in Alzheimer’s disease: a systematic review and meta-analysis

  2021cites this paper
• Genetic Variability in Molecular Pathways Implicated in Alzheimer's Disease: A Comprehensive Review

  2021cites this paper
• Effects of Gene and Plasma Tau on Cognitive Impairment in Rural Chinese Population.

  2021cites this paper
• Single-nucleus chromatin accessibility and transcriptomic characterization of Alzheimer’s disease

  2021cites this paper
• Semantic Recollection in Parkinson’s Disease: Functional Reconfiguration and MAPT Variants

  2021cites this paper
• Blood-based traumatic brain injury biomarkers – Clinical utilities and regulatory pathways in the United States, Europe and Canada

  2021cites this paper
• Plasma NT1 Tau is a Specific and Early Marker of Alzheimer's Disease

  2020cites this paper
• Prion-Like Propagation Mechanisms in Tauopathies and Traumatic Brain Injury: Challenges and Prospects

  2020cites this paper
• Four-repeat tauopathies.

  2019cites this paper
• The MAPT H1 Haplotype Is a Risk Factor for Alzheimer’s Disease in APOE ε4 Non-carriers

  2019cites this paper
• Disease-modifying strategies in primary tauopathies.

  2019cites this paper
• Frontrunner in Translation: Progressive Supranuclear Palsy

  2019cites this paper
• Integrative genomics approach identifies conserved transcriptomic networks in Alzheimer’s disease

  2019cites this paper
• Genome-wide association study identifies CD1A associated with rate of increase in plasma neurofilament light in non-demented elders

  2019cites this paper
• MAPT rs242557 variant is associated with hippocampus tau uptake on 18F-AV-1451 PET in non-demented elders

  2019cites this paper
• Genome-wide association study identifies two loci influencing plasma neurofilament light levels

  2018cites this paper
• Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases

  2018cites this paper
• Genome-wide association study identified ATP6V1H locus influencing cerebrospinal fluid BACE activity

  2018cites this paper
• Corticobasal degeneration: key emerging issues

  2018cites this paper
• Association of MAPT haplotype‐tagging polymorphisms with cerebrospinal fluid biomarkers of Alzheimer's disease: A preliminary study in a Croatian cohort

  2018cites this paper
• Roles of tau protein in health and disease

  2017cites this paper
• Tauopathies: Mechanisms and Therapeutic Strategies

  2017cites this paper
• Genome-wide association study identi fi es APOE locus in fl uencing plasma p-tau181 levels

  year unknowncites this paper